Nicole Davarpanah MD JD
Development and Translational Lead, Oncology Immunotherapy, Genentech
Join to View Full Profile
1 DNA WayWashington, DC 20007
Phone+1 650-467-8466
Dr. Davarpanah is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
National Institutes of Health Clinical CenterFellowship, Medical Oncology, 2014 - 2017
MedStar Health Georgetown University/Georgetown HospitalResidency, Internal Medicine, 2006 - 2007
University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Internal Medicine, 2004 - 2006
Boston University School of MedicineClass of 2002
Certifications & Licensure
CA State Medical License 2006 - 2025
DC State Medical License 2006 - 2016
American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 38 citationsUpdated Overall Survival by Circulating Tumor DNA Status from the Phase 3 IMvigor010 Trial: Adjuvant Atezolizumab Versus Observation in Muscle-invasive Urothelial Carc...Thomas Powles, Zoe June Assaf, Viraj Degaonkar, Petros Grivas, Maha Hussain
European Urology. 2024-02-01 - 1 citationsAnalytical validation of a novel comprehensive genomic profiling informed circulating tumor DNA monitoring assay for solid tumors.Daniel R Zollinger, Elizabeth Rivers, Alexander Fine, Yanmei Huang, Joseph Son
Plos One. 2024-01-01 - 14 citationsA Phase 1b/2 Study of Atezolizumab with or Without Bacille Calmette-Guérin in Patients with High-risk Non-muscle-invasive Bladder Cancer.Brant A Inman, Noah M Hahn, Kelly Stratton, Ryan Kopp, Alex Sankin
European Urology Oncology. 2023-06-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
